Back to the Top
Dear Fellow Discussion Group Member:
I wanted to inform you of an upcoming conference topic that may be of
interest to you and/or your colleagues. Please do not hesitate to contact
me if you would like any additional information on IBC's upcoming Early ADME
and Toxicology in Drug Discovery Conference taking place November 16-17,
2000 at the Hilton La Torrey Pines in La Jolla, California or visit the
conference web site at www.ibcusa.com/2564 Some of the topics that the
conference will cover include: High-Throughput ADME/Toxicology, Predictive
and Simulation Tools, Case Studies and ADME/Tox Assays, Drug-Drug
Interactions, Informatics and Data Analysis, In Vitro - In Vivo Correlation,
Validation and Model Systems and Toxicogenomics.
At a time when research productivity in the pharmaceutical industry is
increasing exponentially, the process of turning hits into compounds worthy
of developing still exists as a bottleneck in the process of discovering new
drugs. It has become imperative that the metabolism, pharmacokinetics and
toxicology sectors of the pharmaceutical industry rapidly address the need
to use technologies, higher-throughput screening, and both computational and
simulation approaches to shorten the timeline and increase the success rate
of discovering and developing new therapeutics. IBC's conference, Early
ADME and Toxicology in Drug Discovery will address these growing issues and
provide examples of emerging technologies and new innovative approaches in
ADME and Toxicology.
For detailed conference information or to register, please visit IBC's Early
ADME and Toxicology in Drug Discovery Web site at www.ibcusa.com/2564 or
contact me:
Michael Keenan
IBC USA
Conference Producer
1 Research Drive #400 A
Westborough, MA 01851-5195
(508) 616-5550, ext. 288
mkeenan.-at-.ibcusa.com
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)